Journal of Medicinal Chemistry · 2003 · 74 citations · 7 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAntibacterial PharmacologyAntibacterial PharmacotherapyBeta-lactam ResistanceCarbapenem ResistanceCombination Antimicrobial TherapyPotency OptimizationAmino AcidsBeta-lactamase InhibitorsCarbapenem AntibioticsCarbapenemase EnzymesCyclopropanation ReactionsMechanism-based InhibitorsSerine Beta-lactamasesβ-Lactam Antibiotics
Class A-class C mechanism-based beta-lactamase inhibitors were designed on the basis of the intermediacy of an oxycarbenium species capable of cross-linking with amino acids residues in the active site. Penams 24 and 27 were very potent against AmpC in vitro. The MIC values of 24 in combination with piperacillin against class A and class C producing organisms showed improvement over clinically used tazobactam.
7
β-Lactamases of Increasing Clinical Importance
Karen Bush · Current Pharmaceutical Design · 1999 · 66 citations